èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ããCan-Fite BioPharma Ltd.ã¯ããããèèããã³ççæ§çŸæ£ãCOVID-19ãåèµ·äžå
šã®æ²»çã®ããã®äœååæ²»çè¬ãéçºããŠããŸããå瀟ã®äž»ååè£è¬CF101ïŒãã¯ãªãããœã³ïŒã¯ã也ç¬ã®æ²»çè¬ãšããŠç¬¬IIIçžèšåºè©ŠéšãCOVID-19ã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšã宿œäžã§ãããŸããè现èããã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšãçµäºããéã¢ã«ã³ãŒã«æ§èèªèçã®æ²»çè¬ãšããŠç¬¬IIçžèšåºè©Šéšäžã®CF102ïŒãã¢ãããœã³ïŒãšãåèµ·äžå
šã®æ²»çè¬ãšããŠåèšåºè©Šéšäžã®CF602ãéçºããŠããŸããããã«ãå瀟ã¯A3ARã®åžè²©äºæž¬ãã€ãªããŒã«ãŒè¡æ¶²æ€æ»ããããéçºããŠããŸããCan-Fite BioPharma Ltd.ã¯ããã¯ãªãããœã³ãšãã¢ãããœã³ã®éçºã補é ãåååã«ã€ããŠCMS Medicalãšææºå¥çŽãçµãã§ããŸããå瀟ã¯ãã¬ã³ãççãèªå·±å
ç«ãä»£è¬æ§çŸæ£ã®æ²»çã®ããã®å€§éº»æåã®ç¹å®ã®é
åãç¹å®ããå
±åéçºããããã«ãUnivo Pharmaceuticals ãšææºããŸãããå瀟ã¯ä»¥å㯠Can-Fite Technologies Ltd. ãšããŠç¥ãããŠããŸãããã2001 幎 1 æã« Can-Fite BioPharma Ltd. ã«ç€Ÿåã倿ŽããŸãããCan-Fite BioPharma Ltd. 㯠1994 幎ã«èšç«ãããã€ã¹ã©ãšã«ã®ãã¿ãã»ãã£ã¯ãŽã¡ã«æ¬ç€Ÿã眮ããŠããŸãã